GSK Plans International Expansion Of Stiefel's Dermatology Business
This article was originally published in The Rose Sheet
Executive Summary
As part of a "multi-pronged" strategy for leveraging its acquisition of Stiefel Laboratories, GlaxoSmithKline plans to introduce the Coral Gables, Fla. firm's Rx and nonprescription dermatology brands to a global audience